No Data
No Data
Are Investors Undervaluing Haemonetics (HAE) Right Now?
This Constellation Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Haemonetics Initiated at Overweight by JP Morgan
Analysts Offer Insights on Healthcare Companies: Haemonetics (HAE) and Terns Pharmaceuticals (TERN)
Express News | Haemonetics Corp : JP Morgan Initiates Coverage With Overweight Rating; Price Target $116
Haemonetics' Strategic Divestment to Boost Core Apheresis Focus and Long-term Growth